These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 6339903)

  • 1. Modulation of aromatic amine mutagenicity in Salmonella typhimurium with rat-liver 9000 g supernatant or monolayers of rat hepatocytes as an activation system.
    Holme JA; Haug LT; Dybing E
    Mutat Res; 1983 Apr; 117(1-2):113-25. PubMed ID: 6339903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity and DNA damage induced by arylamines in the Salmonella/hepatocyte system.
    Staiano N; Erickson LC; Smith CL; Marsden E; Thorgeirsson SS
    Carcinogenesis; 1983; 4(2):161-7. PubMed ID: 6337737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of conjugation reactions on the mutagenicity of aromatic amines.
    Hongslo J; Haug LT; Wirth PJ; Møller M; Dybing E; Thorgeirsson SS
    Mutat Res; 1983 Feb; 107(2):239-47. PubMed ID: 6346076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species differences in the cytotoxic and genotoxic effects of 2-acetylaminofluorene and its primary metabolites 2-aminofluorene and N-OH-2-acetylaminofluorene.
    Holme JA; Søderlund EJ
    Carcinogenesis; 1985 Mar; 6(3):421-5. PubMed ID: 3978756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic activation of 2-aminofluorene, 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene to bacterial mutagens with mussel (Mytilus galloprovincialis) and carp (Cyprinus carpio) subcellular preparations.
    Kurelec B; Krca S
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 88(1):171-7. PubMed ID: 2890481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of genotoxic and cytotoxic effects of aromatic amines in monolayers of rat hepatocytes.
    Holme JA; Søderlund EJ
    Cell Biol Toxicol; 1984 Oct; 1(1):95-110. PubMed ID: 6400924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotoxicity of N-acetylarylamines in the salmonella/hepatocyte system.
    Thorgeirsson SS; Erickson LC; Smith CL; Glowinski IB
    Environ Health Perspect; 1983 Mar; 49():141-5. PubMed ID: 6339222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of selenium of the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives.
    Jacobs MM; Matney TS; Griffin AC
    Cancer Lett; 1977 May; 2(6):319-22. PubMed ID: 324608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genotoxicity of aromatic amines in primary hepatocytes isolated from C57BL/6 and DBA/2 mice.
    Møller ME; Glowinski IB; Thorgeirsson SS
    Carcinogenesis; 1984 Jun; 5(6):797-804. PubMed ID: 6722987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of 2-aminofluorene in the mutagenic activation of 2-acetylaminofluorene.
    Robertson IG
    Mutat Res; 1986 Nov; 175(3):153-7. PubMed ID: 3534560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic activation of aromatic amines by a human hepatoma cell (Hep G2) supernatant tested by means of Salmonella typhimurium strains with different acetyltransferase activities.
    Duverger-van Bogaert M; Dierickx PJ; Crutzen MC
    Mutat Res; 1995 Dec; 335(3):219-27. PubMed ID: 8524336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity-enhancing effect of quercetin on the active metabolites of 2-acetylaminofluorene with mammalian metabolic activation systems.
    Ogawa S; Hirayama T; Tokuda M; Hirai K; Fukui S
    Mutat Res; 1987 Apr; 190(4):241-6. PubMed ID: 3550450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
    Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
    Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and mutagenicity of aromatic amines by human fetal liver.
    Aune T; Haugen A; Dybing E
    Arch Toxicol; 1985 Jun; 57(2):136-8. PubMed ID: 4026573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of butylated hydroxytoluene-mediated modulation of 2-acetylaminofluorene mutagenicity in rat and human hepatocyte/Salmonella assays.
    Chipman JK; Davies JE; Paterson P
    Mutat Res; 1987 Mar; 187(3):105-12. PubMed ID: 3547109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of the mutagenicity of aromatic amines by protein kinases and phosphatases. I. The protein phosphatase inhibitors okadaic acid and ortho-vanadate drastically reduce the mutagenicity of aromatic amines.
    Oesch-Bartlomowicz B; Arens HJ; Richter B; Hengstler JG; Oesch F
    Arch Toxicol; 1997; 71(10):601-11. PubMed ID: 9332696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deacetylation to 2-aminofluorene as a major initial reaction in the microsomal metabolism of 2-acetylaminofluorene to mutagenic products in preparations from rabbit lung and liver.
    Aune T; Vanderslice RR; Croft JE; Dybing E; Bend JR; Philpot RM
    Cancer Res; 1985 Nov; 45(11 Pt 2):5859-66. PubMed ID: 4053056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the mutagenic effects of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) in bacteria with rat-liver 9000 x g supernatant or monolayers of rat hepatocytes as an activation system.
    Holme JA; Brunborg G; Alexander J; Trygg B; Bjørnstad C
    Mutat Res; 1988 Jan; 197(1):39-49. PubMed ID: 3275882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment.
    Traynor CA; Shane BS; Hajos AK; Winston GW
    Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between DNA strand breaks and specific DNA adducts in murine hepatocytes following in vivo and in vitro exposure to N-hydroxy-2-acetylaminofluorene and N-acetoxy-2-acetylaminofluorene.
    Vu VT; Møller ME; Grantham PH; Wirth PJ; Thorgeirsson SS
    Carcinogenesis; 1985 Jan; 6(1):45-52. PubMed ID: 4038475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.